Browse All Treatments

Showing 1856 records.


Page 10 of 186 1 8 9 10 11 12 186
Order by:
SurvivalPatientsToxicityTreatmentHospitalCountryDate
9135.2 monthsRecurrent platinum-sensitive ovarian cancer, primary fallopian tube cancer, primary peritoneal cancer5Chemotherapy, Biologic therapyMemorial Sloan-Kettering Cancer CenterUnited StatesJun 2012
Treatment Details: Patients: This phase 3 study involved platinum-sensitive recurrent ovarian, primary peritoneal, or fallopian tube cancer patients who had received prior platinum-based chemotherap... read more
9235.2 monthsRecurrent platinum-sensitive ovarian cancer5ChemotherapyMemorial Sloan-Kettering Cancer CenterUnited StatesJun 2012
Treatment Details: Patients: This phase 3 study involved platinum-sensitive recurrent ovarian, primary peritoneal, or fallopian tube cancer patients who had received prior platinum-based chemotherap... read more
9335.0 monthsMetastatic hormone-refractory prostate cancer5ImmunotherapySeattle Cancer Care AllianceUnited StatesSep 2008
Treatment Details: Patients: This phase I/II study involved 80 men with metastatic, hormone refractory prostate cancer. Their median age was 69, ranging from 49 to 90 years old. Treatment: Pat... read more
9435.0 monthsGBM2RadiationResearch Center for Charged Particle TherapyJapanOct 2007
Treatment Details: Patients: This phase I/II trial involved 48 patients with malignant gliomas. Sixteen patients had anaplastic astrocytoma and 32 had glioblastoma multiforme. The median age was 5... read more
9535.0 monthsRecurrent Ovarian Cancer4Chemotherapy, SurgeryUniversity of Nice-Sophia AntipolisFranceApr 2015
Treatment Details: Patients: This study involved 15 elderly recurrent ovarian cancer patients with a median age of 72 years (range: 70-77). Treatment: Patients received surgery and chemotherapy ... read more
9634.7 monthsMetastatic, Castration-Resistant Prostate Cancer5HormoneUCSF Helen Diller Family Comprehensive Cancer CenterUnited StatesFeb 2015
Treatment Details: Patients: This phase 3 study involved chemotherapy-naïve metastatic castration-resistant prostate cancer patients who were separated into two treatment groups. Group A consisted o... read more
9734.7 monthsEpithelial ovarian cancer and fallopian tube or primary peritoneal carcinoma4ChemotherapyUniversity Medical Center GroningenNetherlandsJun 2012
Treatment Details: Patients: This study involved women with epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas. Patients were divided into two separate treatment groups. Gr... read more
9834.6 monthsAdvanced breast cancer4ChemotherapyRegina Elena National Cancer InstituteItalyApr 2011
Treatment Details: Patients: This study involved women with advanced breast cancer who had not received prior anthracycline-based therapy. Patients were divided into two separate treatment groups. ... read more
9934.4 monthsEpithelial ovarian cancer4Chemotherapy, Biologic therapyEvangelisches KrankenhausGermanyAug 2012
Treatment Details: Patients: This study involved women with epithelial ovarian cancer who had had no prior radiotherpy or chemotherapy. Patients were divided into two separate treatment groups. Gr... read more
10034.3 monthsEpithelial ovarian cancer and fallopian tube or primary peritoneal carcinoma4ChemotherapyUniversity Medical Center GroningenNetherlandsJun 2012
Treatment Details: Patients: This study involved women with epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas. Patients were divided into two separate treatment groups. Gr... read more
Page 10 of 186 1 8 9 10 11 12 186